# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001437749-19-024112
Filing Date
2019-12-10
Accepted
2019-12-10 08:44:11
Documents
27
Period of Report
2019-12-10
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 8-K | dffn20191209_8k.htm | 8-K | 23823
2 | EXHIBIT 99.1 | ex_166974.htm | EX-99.1 | 14670
3 |  | slide01.jpg | GRAPHIC | 39749
4 |  | slide02.jpg | GRAPHIC | 164810
5 |  | slide03.jpg | GRAPHIC | 74050
6 |  | slide04.jpg | GRAPHIC | 61412
7 |  | slide05.jpg | GRAPHIC | 95889
8 |  | slide06.jpg | GRAPHIC | 100341
9 |  | slide07.jpg | GRAPHIC | 53627
10 |  | slide08.jpg | GRAPHIC | 93681
11 |  | slide09.jpg | GRAPHIC | 45505
12 |  | slide10.jpg | GRAPHIC | 61094
13 |  | slide11.jpg | GRAPHIC | 68040
14 |  | slide12.jpg | GRAPHIC | 107829
15 |  | slide13.jpg | GRAPHIC | 83827
16 |  | slide14.jpg | GRAPHIC | 87437
17 |  | slide15.jpg | GRAPHIC | 68629
18 |  | slide16.jpg | GRAPHIC | 74265
19 |  | slide17.jpg | GRAPHIC | 51567
20 |  | slide18.jpg | GRAPHIC | 75433
21 |  | slide19.jpg | GRAPHIC | 86743
22 |  | slide20.jpg | GRAPHIC | 75790
23 |  | slide21.jpg | GRAPHIC | 110359
24 |  | slide22.jpg | GRAPHIC | 87276
25 |  | slide23.jpg | GRAPHIC | 64171
26 |  | slide24.jpg | GRAPHIC | 61783
27 |  | slide25.jpg | GRAPHIC | 33642
| Complete submission text file | 0001437749-19-024112.txt |  | 2695802

Mailing Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902
Business Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Filer) CIK: 0001053691 (see all company filings)

EIN.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37942 | Film No.: 191276588
SIC: 2834 Pharmaceutical Preparations